Shantha Biotech's Shan-5, its 5-in-1 vaccine, disqualified by the WHO on quality concerns, is now up for reassesment.
The World Health Organization (WHO) troubles for Shantha Biotech, the Indian vaccine unit of Sanofi Aventis seem to be on their way out.